Sotera Health (NASDAQ:SHC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Sotera Health (NASDAQ:SHC - Get Free Report) has been given an average rating of "Moderate Buy" by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $15.70.

A number of analysts have weighed in on SHC shares. Royal Bank of Canada restated an "outperform" rating and set a $17.00 target price on shares of Sotera Health in a report on Tuesday, August 6th. Barclays raised their price objective on Sotera Health from $14.00 to $17.00 and gave the company an "overweight" rating in a research report on Tuesday, August 6th.

Sotera Health Trading Down 1.4 %

Sotera Health stock traded down $0.24 during mid-day trading on Wednesday, hitting $16.59. The company's stock had a trading volume of 1,104,551 shares, compared to its average volume of 1,363,134. Sotera Health has a one year low of $10.71 and a one year high of $17.44. The stock has a market cap of $4.70 billion, a PE ratio of 87.22 and a beta of 2.07. The company has a 50 day moving average of $15.04 and a 200-day moving average of $12.88. The company has a debt-to-equity ratio of 5.46, a quick ratio of 2.59 and a current ratio of 2.93.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.04. The company had revenue of $277.00 million for the quarter, compared to analysts' expectations of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. Sotera Health's revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.19 earnings per share. On average, research analysts anticipate that Sotera Health will post 0.64 EPS for the current year.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the sale, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 55.12% of the company's stock.

Hedge Funds Weigh In On Sotera Health

A number of large investors have recently added to or reduced their stakes in the stock. CWM LLC lifted its position in shares of Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company's stock valued at $25,000 after acquiring an additional 993 shares in the last quarter. Swiss National Bank lifted its holdings in Sotera Health by 0.5% in the 1st quarter. Swiss National Bank now owns 195,900 shares of the company's stock valued at $2,353,000 after purchasing an additional 1,000 shares in the last quarter. TD Asset Management Inc boosted its stake in Sotera Health by 1.5% during the 2nd quarter. TD Asset Management Inc now owns 123,454 shares of the company's stock worth $1,465,000 after purchasing an additional 1,800 shares during the last quarter. Securian Asset Management Inc. boosted its stake in Sotera Health by 23.0% during the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company's stock worth $122,000 after purchasing an additional 1,900 shares during the last quarter. Finally, State of Alaska Department of Revenue grew its holdings in shares of Sotera Health by 20.6% during the first quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company's stock worth $162,000 after buying an additional 2,300 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.